Life Science REIT PLC (LABS)

Category Property - Direct UK


Sell

37.10p

Buy

37.90p

arrow-down-1.30p (-3.39%)

Discount/Premium

-49.76%

Estimated NAV

76.232p

Prices updated at 22 Nov 2024, 00:00
| Prices minimum 15 mins delay
|
Prices in GBX

Investment objective
The Company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the UK which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. Life science is the branch of sciences concerned with the study of living organisms. This encompasses the study of the breadth of life processes, and the structure and behaviour of living things. Companies operating in the life science sector include, but are not limited to, those involved in the innovation, development and/or production of assets directly or indirectly for human health purposes.

arrow-up1.34%
LSE

Annual performance (%)

This fundPeer group index
30 Sep 13 - 30 Sep 14--
30 Sep 14 - 30 Sep 15--
30 Sep 15 - 30 Sep 16--
30 Sep 16 - 30 Sep 17--
30 Sep 17 - 30 Sep 18--
30 Sep 18 - 30 Sep 19--
30 Sep 19 - 30 Sep 20--
30 Sep 20 - 30 Sep 21--
30 Sep 21 - 30 Sep 22--
30 Sep 22 - 30 Sep 232.89-10.23
30 Sep 23 - 30 Sep 24-42.469.46

Primary benchmark: No benchmark

Peer group index: Morningstar IT Property - UK Commercial

Trailing returns (%)

This fundPeer group index
1 Day-3.390.70
1 Month-5.130.62
3 Months9.613.25
6 Months5.945.19
1 Year-40.992.91
3 Years annualised-25.10-5.02
5 Years annualised--

Primary benchmark: No benchmark

Peer group index: Morningstar IT Property - UK Commercial

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2024 Morningstar. All rights reserved.